XML 21 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net loss $ (120,088) $ (31,781) $ (57,107)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 357 462 738
Stock-based compensation 7,997 4,743 3,507
Change in fair value of warrants   (11,723) (1,185)
Common stock issued in exchange for license agreement 67,285    
Loss on disposal of fixed assets     585
(Increase) decrease in:      
Receivables (301)   (87)
Prepaid expenses and other current assets (10,214) 809 4,964
Other noncurrent assets (3) 37 477
Increase (decrease) in:      
Accounts payable 4 1,582 (1,087)
Accrued expenses 1,724 827 (10,159)
Deferred revenue 53,418 (1,373) (800)
Deferred rent (189) (213) 625
Other noncurrent liabilities   (20) 20
Net cash used in operating activities (10) (36,650) (59,509)
Cash flows from investing activities:      
Purchases of property and equipment (412) (193) (132)
Proceeds from sale of property and equipment     1
Net cash used in investing activities (412) (193) (131)
Cash flows from financing activities:      
Proceeds from exercise of stock options 4,568 1,386 956
Payments to employees for repurchase of restricted common stock (518) (544) (498)
Proceeds from exercise of warrants   10,600 200
Repurchase of common stock (34)    
Proceeds from issuance of common stock, net 94,320   53,880
Net cash provided by financing activities 98,336 11,442 54,538
Net increase (decrease) in cash and cash equivalents 97,914 (25,401) (5,102)
Cash and cash equivalents, beginning of period 42,803 68,204 73,306
Cash and cash equivalents, end of period 140,717 42,803 68,204
Supplementary disclosure of cash flow information:      
Cash paid for interest 0 0 0
Cash paid for income taxes 0 0 0
Supplementary disclosure of noncash investing and financing activities:      
Exercise of equity-classified warrants to common shares   692 $ 196
Issuance of common stock in license agreement $ 67,285    
Exercise of liability-classified warrants to common shares   $ 54